ID

10571

Descrizione

S0023 ZD1839 DOSE AND TOXICITY REPORTING FORM NCT00020709 S0023: Combination Chemo Plus RT With or Without Gefitinib in Treating Patients With Unresectable Stage III NSCLC Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9CA62D43-50BE-361C-E034-080020C9C0E0

collegamento

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9CA62D43-50BE-361C-E034-080020C9C0E0

Keywords

versioni (3)
  1. 19/09/12 19/09/12 -
  2. 28/05/15 28/05/15 -
  3. 03/06/15 03/06/15 -
Caricato su

3 giugno 2015

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0 Legacy
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

S0023 ZD1839 DOSE AND TOXICITY REPORTING FORM NCT00020709

Inglese

No Instruction available.

1 moduli  
  1. StudyEvent: S0023 ZD1839 DOSE AND TOXICITY REPORTING FORM
    1. No Instruction available.
SWOG clinical trial administrative data
Descrizione

SWOG clinical trial administrative data

SWOG Patient ID
Descrizione

SWOGPatientID

Tipo di dati

text

SWOG Study No.
Descrizione

SWOGStudyNo.

Tipo di dati

text

Registration Step
Descrizione

RegistrationStep

Tipo di dati

text

Alias
NCI Thesaurus ValueDomain
C25337
UMLS 2011AA ValueDomain
C0237753
NCI Thesaurus ValueDomain
C16154
UMLS 2011AA ValueDomain
C1704379
Submission Time
Descrizione

SubmissionTime:

Tipo di dati

text

Patient Initials (L, F,M)
Descrizione

PatientInitials

Tipo di dati

text

Institution / Affiliate
Descrizione

Institution/Affiliate

Tipo di dati

text

Physician
Descrizione

Physician

Tipo di dati

text

Group Name (Groups other than SWOG )
Descrizione

GroupName

Tipo di dati

text

Study No. (Groups other than SWOG )
Descrizione

StudyNo.

Tipo di dati

double

Pt. ID (Groups other than SWOG )
Descrizione

Pt.ID

Tipo di dati

text

Treatment
Descrizione

Treatment

Reporting Begin Date (4 week period)
Descrizione

ReportingBeginDate:

Tipo di dati

text

Reporting End Date
Descrizione

ReportingEndDate:

Tipo di dati

text

Were there any dose modifications or additions/deletions to protocol treatment?
Descrizione

Werethereanydosemodificationsoradditions/deletionstoprotocoltreatment?

Tipo di dati

text

Delay
Descrizione

Delay:

Tipo di dati

text

Dose reduction
Descrizione

Dosereduction:

Tipo di dati

text

Total dose for this reporting period (mg ZD1839 1 Tablet = 250 mg)
Descrizione

Totaldoseforthisreportingperiod:

Tipo di dati

text

Toxicity
Descrizione

Toxicity

Were toxicities assessed during this time period?
Descrizione

Weretoxicitiesassessedduringthistimeperiod?

Tipo di dati

text

Date of most recent toxicity assessment
Descrizione

Dateofmostrecenttoxicityassessment:

Tipo di dati

text

CTC 2.0 Code
Descrizione

CTC2.0Code

Tipo di dati

text

Toxicity
Descrizione

Toxicity

Tipo di dati

text

Grade (1 - 5)
Descrizione

Grade

Tipo di dati

double

Treatment Relation
Descrizione

TreatmentRelation

Tipo di dati

text

Other Toxicities (specify:)
Descrizione

OtherToxicities

Tipo di dati

text

Notes
Descrizione

Notes

Notes
Descrizione

Notes

Tipo di dati

text

Ritorna all'inizio della pagina

Similar models

No Instruction available.

1 moduli
  1. StudyEvent: S0023 ZD1839 DOSE AND TOXICITY REPORTING FORM
    1. No Instruction available.
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
SWOG clinical trial administrative data
SWOGPatientID
Item
SWOG Patient ID
text
SWOGStudyNo.
Item
SWOG Study No.
text
RegistrationStep
Item
Registration Step
text
C25337 (NCI Thesaurus ValueDomain)
C0237753 (UMLS 2011AA ValueDomain)
C16154 (NCI Thesaurus ValueDomain)
C1704379 (UMLS 2011AA ValueDomain)
Item
Submission Time
text
CL.1
Code List
Submission Time
CL Item
4 week (First) Submission (4 week (First) Submission)
CL Item
8 week (Second) Submission (8 week (Second) Submission)
CL Item
Other (Other)
PatientInitials
Item
Patient Initials (L, F,M)
text
Institution/Affiliate
Item
Institution / Affiliate
text
Physician
Item
Physician
text
GroupName
Item
Group Name (Groups other than SWOG )
text
StudyNo.
Item
Study No. (Groups other than SWOG )
double
Pt.ID
Item
Pt. ID (Groups other than SWOG )
text
Item Group
Treatment
ReportingBeginDate:
Item
Reporting Begin Date (4 week period)
text
ReportingEndDate:
Item
Reporting End Date
text
Item
Were there any dose modifications or additions/deletions to protocol treatment?
text
CL.2
Code List
Were there any dose modifications or additions/deletions to protocol treatment?
CL Item
No (No)
CL Item
Yes, planned (per protocol guidelines) (Yes, planned (per protocol guidelines))
CL Item
Yes, unplanned (not per protocol guidelines) (Yes, unplanned (not per protocol guidelines))
Item
Delay
text
CL.3
Code List
Delay
CL Item
Yes (Yes)
CL Item
No (No)
Item
Dose reduction
text
CL.4
Code List
Dose reduction
CL Item
Yes (Yes)
CL Item
No (No)
Totaldoseforthisreportingperiod:
Item
Total dose for this reporting period (mg ZD1839 1 Tablet = 250 mg)
text
Item Group
Toxicity
Item
Were toxicities assessed during this time period?
text
CL.5
Code List
Were toxicities assessed during this time period?
CL Item
No (No)
CL Item
Yes (Yes)
Dateofmostrecenttoxicityassessment:
Item
Date of most recent toxicity assessment
text
Item
CTC 2.0 Code
text
CL.6
Code List
CTC 2.0 Code
CL Item
SK11 (SK11)
CL Item
EY01 (EY01)
CL Item
EY02 (EY02)
CL Item
EY30 (EY30)
CL Item
EY40 (EY40)
CL Item
EY99 (EY99)
CL Item
FL40 (FL40)
CL Item
LI00 (LI00)
CL Item
LI12 (LI12)
CL Item
GI00 (GI00)
CL Item
GI01 (GI01)
CL Item
GI10 (GI10)
CL Item
GI20 (GI20)
CL Item
GU50 (GU50)
CL Item
HE00 (HE00)
CL Item
HE10 (HE10)
CL Item
HE20 (HE20)
CL Item
HE30 (HE30)
CL Item
IM00 (IM00)
CL Item
IN00 (IN00)
CL Item
IN05 (IN05)
CL Item
IN30 (IN30)
Item
Toxicity
text
CL.7
Code List
Toxicity
CL Item
Rash/Desquamation (Rash/Desquamation)
CL Item
Conjunctivitis (Conjunctivitis)
CL Item
Keratitis (Keratitis)
CL Item
Tearing (Tearing)
CL Item
Vision, NOS (Vision, NOS)
CL Item
Eye, Other (Eye, Other)
CL Item
Fatigue (Fatigue)
CL Item
Bilirubin increase (Bilirubin increase)
CL Item
SGPT increase (SGPT increase)
CL Item
Nausea (Nausea)
CL Item
Anorexia (Anorexia)
CL Item
Vomiting (Vomiting)
CL Item
Diarrhea (Diarrhea)
CL Item
Creatinine increase (Creatinine increase)
CL Item
Leukopenia (Leukopenia)
CL Item
Thrombocytopenia (Thrombocytopenia)
CL Item
Anemia (Anemia)
CL Item
Neutropenia/granulocytopenia (Neutropenia/granulocytopenia)
CL Item
Allergy/hypersensitivity (Allergy/hypersensitivity)
CL Item
Infection w/o 3-4 neutropenia (Infection w/o 3-4 neutropenia)
CL Item
Infection with 3-4 neutropenia (Infection with 3-4 neutropenia)
CL Item
Febrile neutropenia (Febrile neutropenia)
Grade
Item
Grade (1 - 5)
double
Item
Treatment Relation
text
CL.8
Code List
Treatment Relation
CL Item
unrelated (unrelated)
CL Item
unlikely (unlikely)
CL Item
possible (possible)
CL Item
probable (probable)
CL Item
definite (definite)
OtherToxicities
Item
Other Toxicities (specify:)
text
Item Group
Notes
Notes
Item
Notes
text
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial